ArticleJournal of virology2012

Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.

Swati Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.